Skip to main content
OpenTrials
Completed

NCT Number: NCT01427088

rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia

This study aims at investigating the neuroplastic potential and the possible factors affecting rehabilitation in chronic schizophrenia patients on stable medication, by investigating the cumulative pattern of serum BDNF representing the neuroplasticity in the brain, through quantitative stimulus such as rTMS.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jeonbuk Provincial Maeumsarang Hospital

Wanju, Jeollabuk-do, 565844, South Korea

About this study

Subjects who have been enrolled for this study will take baseline evaluation for sociodemographic data and serum level of BDNF, plasma Prolaction, and magnesium, etc. And then, weekday regular stimulation through rTMS will be applied on DLPFC of brain. After the completion of stimulation for 2 weeks, the change or response of serum BDNF will be analyzed and compared.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • duration of illness over 10 years
  • on stable medication, antipsychotics
  • no change on medication within at least 2 weeks
  • Diagnosis of Schizophrenia according to DSM-IV-TR

Exclusion criteria

  • left or both-handedness
  • anticonvulsant use
  • lorazepam equivalent over 3 mg

Treatment and study plan

CR Technology, TAMAS for repetitive TMS

Device

repetitive TMS, lef DLPFC, 20Hz, 100% of MEP, 2weeks

Primary outcomes

  1. change from baseline of serum BDNF concentration

    Time frame: baseline-1 week-2 week-4 week

Sponsors and collaborators

Lead sponsor

Jeonbuk Provincial Maeumsarang Hospital

Other

Registry information

Official study title

Short-Term Response of Serum Brain-Derived Neurotrophic Factor to Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Schizophrenia

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Sep 1, 2011
Registry last updated
Feb 18, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.